Literature DB >> 8642195

Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes.

C Boeckler1, B Frisch, S Muller, F Schuber.   

Abstract

We have investigated the immunogenicity of six thiol-reactive heterobifunctional cross-linking reagents that permit the conjugation of cysteine carrying peptides to the surface of liposome containing monophosphoryl lipid A. Such constructs elicit an immune response against short synthetic peptides and our aim was to find the least immunogenic linkers to limit potential carrier-induced epitopic suppression. For that purpose the properties of three new polyoxyethylene linkers of different lengths and thiol-reactive moieties (maleimide, bromoacetyl, dithiopyridine) were compared to known derivatives obtained by reacting the classical reagents SMPB and SPDP or N-succinimidyl bromoacetate with phosphatidylethanolamine. The least immunogenic linkers were the bromoacetate derivatives whereas those containing a maleimide group evoked a significant anti-linker immune response. In addition, using IRGERA as a model peptide, we found that all six liposomal constructs strongly elicited the production of anti-peptide IgG antibodies. This immune response was therefore independent of the length of the linkers (ranging between 0.3 and 1.6 nm) and of the nature of the linkage. between the peptide and the thiol-reactive moieties of the cross-linkers, i.e. stable thioether or bio-reducible disulfide bonds.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642195     DOI: 10.1016/0022-1759(95)00284-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory.

Authors:  Rachael M Crist; Jennifer Hall Grossman; Anil K Patri; Stephan T Stern; Marina A Dobrovolskaia; Pavan P Adiseshaiah; Jeffrey D Clogston; Scott E McNeil
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

2.  Immune responses to coiled coil supramolecular biomaterials.

Authors:  Jai S Rudra; Pulak K Tripathi; David A Hildeman; Jangwook P Jung; Joel H Collier
Journal:  Biomaterials       Date:  2010-08-12       Impact factor: 12.479

3.  Studies on the reductive amination of 3-deoxy-D-manno-octulosonic acid (Kdo).

Authors:  H D Grimmecke; H Brade
Journal:  Glycoconj J       Date:  1998-06       Impact factor: 2.916

4.  Biotargeted nanomedicines for cancer: six tenets before you begin.

Authors:  Michael S Goldberg; Sara S Hook; Andrew Z Wang; Jeff W M Bulte; Anil K Patri; Fatih M Uckun; Vincent L Cryns; Justin Hanes; Demir Akin; Jennifer B Hall; Nastaran Gharkholo; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2013-02       Impact factor: 5.307

5.  Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba.

Authors:  Cyrille Grandjean; Alain Boutonnier; Bruno Dassy; Jean-Michel Fournier; Laurence A Mulard
Journal:  Glycoconj J       Date:  2008-07-23       Impact factor: 2.916

6.  A Targeting Microbubble for Ultrasound Molecular Imaging.

Authors:  James Shue-Min Yeh; Charles A Sennoga; Ellen McConnell; Robert Eckersley; Meng-Xing Tang; Sussan Nourshargh; John M Seddon; Dorian O Haskard; Petros Nihoyannopoulos
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

7.  A modular synthetic route to size-defined immunogenic Haemophilus influenzae b antigens is key to the identification of an octasaccharide lead vaccine candidate.

Authors:  J Y Baek; A Geissner; D C K Rathwell; D Meierhofer; C L Pereira; P H Seeberger
Journal:  Chem Sci       Date:  2017-12-11       Impact factor: 9.825

8.  Constructing conjugate vaccine against Salmonella Typhimurium using lipid-A free lipopolysaccharide.

Authors:  Tzu-Wei Chiu; Chi-Jiun Peng; Ming-Cheng Chen; Mei-Hua Hsu; Yi-Hua Liang; Cheng-Hsun Chiu; Jim-Min Fang; Yuan Chuan Lee
Journal:  J Biomed Sci       Date:  2020-08-24       Impact factor: 8.410

9.  Masking terminal neo-epitopes of linear peptides through glycosylation favours immune responses towards core epitopes producing parental protein bound antibodies.

Authors:  Robert Pon; Anne Marcil; Wangxue Chen; Christine Gadoury; Dean Williams; Kenneth Chan; Hongyan Zhou; Amalia Ponce; Eric Paquet; Komal Gurnani; Anindita Chattopadhyay; Wei Zou
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.